Navigation Links
BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC
Date:9/4/2007

The most powerful inflammation fighter of any known botanical now widely

available

EGG HARBOR TOWNSHIP., N.J., Sept. 4 /PRNewswire/ -- BSP Pharma Inc., based in Egg Harbor Township, NJ, has announced the distribution of its new, all natural dietary supplement FlexNow(TM) Joint Formula in Vitamin Shoppe stores (http://www.vitaminshoppe.com) nationally as well as at select GNC stores (http://www.gnc.com) throughout the country.

"With the national launch of FlexNow Joint Formula earlier this year, we are continuing to see success and demand for our product," stated Leonard P. Smith, CEO and President of BSP Pharma Inc. "Distribution in Vitamin Shoppe and select GNC outlets introduces FlexNow to a larger market and to those suffering from chronic joint discomfort," he added.

FlexNow(TM) Joint Formula is an all natural dietary supplement made with one ingredient: shea nut triterpenes, the most powerful inflammation fighter of any known botanical. Harvested in the wild in West Africa, the shea nut (the nut is actually the pit of the shea fruit) which produces shea oil has been used for centuries as a food product and more recently as an effective additive to cosmetics and moisturizers (shea butter). Research revealed that the shea nut contains the most unique complex of Nature's Inflammation Fighters(TM), triterpenes, of any known botanical.

Since inflammation is a primary contributor to joint problems, BSP Pharma conducted pharmacological and clinical research into the anti-inflammatory properties of triterpene esters found in the shea nut triterpenes. Positive results led the way to the development of FlexNow Joint Formula. Reports on the clinical studies are available at: http://www.FlexNow.us Extensive research on shea nut triterpene extract also proved safety, including lack of gastric lesions.

FlexNow Joint Formula was one of only seven dietary supplement products accepted by the FDA in 2004 to meet all the safety requirements under the Dietary Supplement Health and Education Act. FlexNow offers a full guarantee, complete relief in 30 days or complete refund.

About BSP Pharma

BSP Pharma Inc., a subsidiary of BSP Pharma A/S of Denmark, is based in Egg Harbor Township, NJ, and was formed in 2005 to bring the remarkable shea nut health products to market. BSP's CEO and President Leonard P. Smith has held senior level positions in the nutraceutical and pharmaceutical industry for more than 20 years. At Lactaid Inc. he led the company's flagship product, Lactaid(R), through explosive growth. While running Lactaid(R), Smith developed Beano(R), a successful legend in the nutraceutical field. For product availability and additional information visit the company's website http://www.FlexNow.us.

Lactaid(R) is a registered trademark of Johnson & Johnson.

Beano(R) is a registered trademark of GlaxoSmithKline.


'/>"/>
SOURCE BSP Pharma Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Analyzing Trace-Level Impurities of a Pharmaceutical Intermediate Using an LCQ Deca Ion Trap Mass Spectrometer and the Mass Frontier Software Package
2. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
3. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
4. Practical Applications of HyperDSC in a Pharmaceutical Laboratory
5. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
6. Germantown drug company hires pharma veteran James Davidson as COO
7. Deltanoid Pharmaceuticals begins phase II osteoporosis study
8. New angel capital centered on GenTel agreement with big pharma
9. The deconstruction of Big Pharma
10. Big pharma seeks Wisconsin biotech partnerships
11. Doing the pharmaceutical tango
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)... -- Liquid Biotech USA , Inc. ... Research Agreement with The University of Pennsylvania ("PENN") ... patients.  The funding will be used to assess ... outcomes in cancer patients undergoing a variety of ... to support the design of a therapeutic, decision-making ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader ... “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, ... providing practical tips, tools, and strategies for clinical researchers. , “The landscape of ...
Breaking Biology Technology:
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
Breaking Biology News(10 mins):